WGS - GeneDx Holdings Corp.

68.53
2.290   3.342%

Share volume: 457,193
Last Updated: 04-24-2026
Healthcare/Services – Health: 0.01%

PREVIOUS CLOSE
CHG
CHG%
$66.24
2.29
0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
44%
Profitability 35%
Dept financing 27%
Liquidity 50%
Performance 55%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-1.86%
1 Month
20.04%
3 Months
-28.62%
6 Months
-47.55%
1 Year
-39.08%
2 Year
523.00%
Key data
Stock price
$68.53
P/E Ratio 
0.00
DAY RANGE
$64.91 - $69.09
EPS 
-$0.73
52 WEEK RANGE
$55.17 - $170.87
52 WEEK CHANGE
-$39.08
MARKET CAP 
3.759 B
YIELD 
N/A
SHARES OUTSTANDING 
29.289 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.18
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$617,406
AVERAGE 30 VOLUME 
$650,662
Company detail
CEO: Katherine A. Stueland
Region: US
Website: sema4.com
Employees: 1,200
IPO year: 2020
Issue type: Common Stock
Market: XNAS
Industry: Healthcare/Services – Health
Sector: Services

Sema4 Holdings Corp. operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commercialization life-cycle.

Recent news